Adma Biologics | ADMA - Beban Penjualan Dan Administrasi

Harga Saham
13.13
Perubahan Harian
-0.47 -3.42%
Bulanan
-16.29%
Tahunan
-35.09%
Q1 Perkiraan
13.89




Beban Penjualan Dan Administrasi Perubahan Tanggal
Adma Biologics USD 20.19M 2.86M 2025-12
Alnylam Pharmaceuticals USD 285.06M 22.47M 2025-12
BioCryst Pharmaceuticals USD 95.78M 12.77M 2025-12
Minerva Neurosciences USD 2.48M 58.79K 2024-09
Novavax USD 25.53M 1.34M 2025-12
Omeros USD 11.32M 2.48M 2024-09
Takeda JPY 282.78B 29.23B 2025-12